Cargando…

Pharmacological targeting of HMGB-1 translocation: A potential therapeutic strategy for COVID-19

Detalles Bibliográficos
Autor principal:	Bagheri, Vahid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477604/ https://www.ncbi.nlm.nih.gov/pubmed/36116707 http://dx.doi.org/10.1016/j.phrs.2022.106455

Ejemplares similares

Pharmacological targeting of one‑carbon metabolism as a novel therapeutic strategy for glioblastoma
por: Sun, Yanfei, et al.
Publicado: (2023)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

HMGB1 as a potential biomarker and therapeutic target for severe COVID-19
por: Chen, Ruochan, et al.
Publicado: (2020)

Targeting HMGB1: A Potential Therapeutic Strategy for Chronic Kidney Disease
por: Liu, Tongtong, et al.
Publicado: (2023)

Interleukin-17: A potential therapeutic target in COVID-19
por: Mendoza, Vicky M. Montaño
Publicado: (2020)

The effect of potential therapeutic agents on QT interval in patients with COVID-19 Infection: The importance of close monitoring and correction of electrolytes
por: Habibzadeh, Parham, et al.
Publicado: (2020)

Potential therapeutic role of pharmacological sympathectomy in Martorell ulcer
por: Baglivo, Mirko, et al.
Publicado: (2022)

Therapeutic potential of HMGB1-targeting agents in sepsis
por: Wang, Haichao, et al.
Publicado: (2008)

COVID-19: Brief overview of therapeutic strategies
por: Beaumont, Anne-Lise, et al.
Publicado: (2023)

HMGB1 is upregulated in the airways in asthma and potentiates airway smooth muscle contraction via TLR4
por: Di Candia, Leonarda, et al.
Publicado: (2017)

Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations
por: Shmakova, Anna, et al.
Publicado: (2022)

Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy
por: Dong, Haonan, et al.
Publicado: (2022)

Potential of Exercise as a COVID-19 Prevention Strategy
por: Desapriya, Ediriweera, et al.
Publicado: (2023)

Linezolid a potential treatment for COVID-19 coinfections
por: Moghadam, Vahid Damanpak, et al.
Publicado: (2021)

Location, Location, Location: Appraising the Pleiotropic Function of HMGB1 in Fetal Brain
por: Frasch, Martin G., et al.
Publicado: (2017)

Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
por: Singh, Harbinder, et al.
Publicado: (2022)

HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma
por: Wang, Yanbin, et al.
Publicado: (2019)

Potential Therapeutic Effects of Virgin Coconut Oil on COVID-19
por: Ghorbannezhad, Ghazaleh, et al.
Publicado: (2022)

Clofazimine: A potential therapeutic option for severe COVID-19
por: Ateya, Areej Mohamed
Publicado: (2021)

COVID-19 in the endoscopy ward: A potential risk for gastroenterologists
por: Hormati, Ahmad, et al.
Publicado: (2020)

Complement activation in patients with COVID-19: A novel therapeutic target
por: Cugno, Massimo, et al.
Publicado: (2020)

Therapeutic potential of N-acetyl cysteine during COVID-19 epoch
por: Kapur, Ajita, et al.
Publicado: (2022)

A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19
por: Esam, Zohreh
Publicado: (2020)

Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid
por: Unal, Gokhan, et al.
Publicado: (2020)

Curcumin inhibits the lymphangiogenesis of gastric cancer cells by inhibiton of HMGB1/VEGF-D signaling
por: Da, Wei, et al.
Publicado: (2019)

HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
por: Ren, Wenxuan, et al.
Publicado: (2023)

HMGB1 cytoplasmic translocation in patients with acute liver failure
por: Zhou, Rong-Rong, et al.
Publicado: (2011)

New therapeutic strategy for atopic dermatitis by targeting CHI3L1/ITGA5 axis
por: Lee, Yong Sun, et al.
Publicado: (2022)

Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID‐19: Shoot the messenger!
por: Habtemariam, Solomon, et al.
Publicado: (2020)

Testing strategies for the control of COVID-19 in nursing homes: Universal or targeted screening?
por: Birgand, Gabriel, et al.
Publicado: (2021)

Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
por: Andersson, Ulf, et al.
Publicado: (2020)

Cyr61: a potential therapeutic target for prostate cancer
por: Lin, Chang-Ming, et al.
Publicado: (2014)

Off‐target ACE2 ligands: Possible therapeutic option for CoVid‐19?
por: Brogi, Simone, et al.
Publicado: (2020)

Therapeutic potential for clomiphene, a selective estrogen receptor modulator, in the treatment of COVID‐19
por: Ghasemnejad-Berenji, Morteza, et al.
Publicado: (2020)

HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target
por: Mao, Di, et al.
Publicado: (2022)

The Emerging Role of HMGB1 in Neuropathic Pain: A Potential Therapeutic Target for Neuroinflammation
por: Wan, Wenbin, et al.
Publicado: (2016)

Re: COVID-19 media fatigue: predictors of decreasing interest and avoidance of COVID-19–related news
por: Karizaki, Vahid Mohammadpour
Publicado: (2021)

Databases for the targeted COVID‐19 therapeutics
por: Wang, Yunxia, et al.
Publicado: (2020)

Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
por: Bennani, N.N., et al.
Publicado: (2020)

HMGB1 neutralization is associated with bacterial translocation during acetaminophen hepatotoxicity
por: Yang, Runkuan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v02qsdpbklatbgiughv527iva1